关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Beijing

Release time:

2023-07-24

Product Name Specifications Conversion ratio
Guipi Capsule 0.3g 24
Guipi Capsule 0.3g 36
Fenofibrate Capsules 0.2g 12
Azithromycin for Injection 0.5g 1
Clindamycin Phosphate Injection 4ml:0.6g 1
Clindamycin Phosphate Injection 2ml:0.3g 1
Lysine for Injection 0.9g (based on lysine) 10
Diammonium glycyrrhizinate enteric-coated tablets 50mg 12
Diammonium glycyrrhizinate enteric-coated tablets 50mg 24
Diammonium glycyrrhizinate enteric-coated tablets 50mg 36
Clindamycin hydrochloride for injection 0.15g 1
Sodium creatine phosphate for injection 0.5g 1
Sodium creatine phosphate for injection 1.0g 1
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs